Application of Risk-Based Cancer Screening in Patients With Dermatomyositis
- PMID: 39320903
- PMCID: PMC11425187
- DOI: 10.1001/jamadermatol.2024.3355
Application of Risk-Based Cancer Screening in Patients With Dermatomyositis
Plain language summary
This cohort study investigates the performance of the International Myositis Assessment and Clinical Studies Group cancer screening recommendations in a community setting.
Conflict of interest statement
Comment on
-
Clinical Application of New Risk-Based Cancer Screening in Patients With Dermatomyositis.JAMA Dermatol. 2024 Nov 1;160(11):1151-1152. doi: 10.1001/jamadermatol.2024.3349. JAMA Dermatol. 2024. PMID: 39320904 No abstract available.
Similar articles
-
Clinical value of cancer-associated myositis-specific antibodies, anti-transcriptional intermediary factor 1-γ, and anti-nuclear matrix protein 2 antibodies in a retrospective cohort of dermatomyositis/polymyositis in a Japanese community hospital.Clin Rheumatol. 2022 Sep;41(9):2803-2808. doi: 10.1007/s10067-022-06166-3. Epub 2022 Apr 11. Clin Rheumatol. 2022. PMID: 35399148
-
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis.Clin Rheumatol. 2017 Feb;36(2):469-475. doi: 10.1007/s10067-016-3453-0. Epub 2016 Oct 20. Clin Rheumatol. 2017. PMID: 27761751
-
Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort.Autoimmun Rev. 2014 Dec;13(12):1211-9. doi: 10.1016/j.autrev.2014.08.011. Epub 2014 Aug 23. Autoimmun Rev. 2014. PMID: 25182203 Review.
-
Risk Factors and Cancer Screening in Myositis.Rheum Dis Clin North Am. 2020 Aug;46(3):565-576. doi: 10.1016/j.rdc.2020.05.006. Epub 2020 Jun 7. Rheum Dis Clin North Am. 2020. PMID: 32631604 Review.
-
Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.Medicine (Baltimore). 2014 Nov;93(24):318-332. doi: 10.1097/MD.0000000000000222. Medicine (Baltimore). 2014. PMID: 25500701 Free PMC article.
References
-
- Oldroyd AGS, Callen JP, Chinoy H, et al. ; International Myositis Assessment and Clinical Studies Group Cancer Screening Expert Group . International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative. Nat Rev Rheumatol. 2023;19(12):805-817. doi:10.1038/s41584-023-01045-w - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
